CNSP Latest Press Releases

-- March 11, 2026 --

CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline ACCESS Newswire 8:35 AM

-- March 2, 2026 --

CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team ACCESS Newswire 8:25 AM

-- February 17, 2026 --

CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation ACCESS Newswire 8:25 AM

-- January 27, 2026 --

CNS Pharmaceuticals Issues Letter to Shareholders ACCESS Newswire 9:00 AM

-- December 17, 2025 --

CNS Pharmaceuticals Announces CEO Transition ACCESS Newswire 7:00 AM

-- November 17, 2025 --

CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update ACCESS Newswire 8:35 AM

-- November 10, 2025 --

CNS Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentation at the Society of NueroOncology (SNO) 30th Annual Meeting ACCESS Newswire 8:45 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software